Cost and utilization of immunotherapy and targeted therapy for melanoma: Cross-sectional analysis in the Medicare population, 2013 and 2015

J Am Acad Dermatol. 2020 Mar;82(3):761-764. doi: 10.1016/j.jaad.2019.10.023. Epub 2019 Oct 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cross-Sectional Studies
  • Health Care Costs*
  • Humans
  • Immunotherapy / economics*
  • Immunotherapy / statistics & numerical data*
  • Medicare
  • Melanoma / therapy*
  • Molecular Targeted Therapy / economics*
  • Molecular Targeted Therapy / statistics & numerical data*
  • Procedures and Techniques Utilization / statistics & numerical data*
  • Time Factors
  • United States